-
-
-
-
-
-
-
Neurogene Announces Upcoming Presentation on the Therapeutic Rationale for ICV Delivery in CNS-Targeted Gene Therapy
-
-
-
-
-
-
-
Neurogene Reports Positive Interim Data in Pediatric Cohort from NGN-401 Gene Therapy Trial for Rett Syndrome
-
-
-
-
-
-
-
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
-
-
-
-
-
-
1,167,431 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

